Refine Results
- Products
- Applications and Industries
- Content Type
- Analysis Platform
- Language
- Publication Date
1 - 5 of 5 results
Applied Filters
Data generated by the Sequencing Quality Control Consortium (SEQC) has shown that RNA-Seq and microarray-based gene expression models are comparable in clinical endpoint prediction performance.
In this study, we modified the existing gene expression microarray protocol to allow processing of samples starting from 250 pg of total RNA.
The WINTHER study demonstrates that that RNA expression testing can be used to tailor precision medicine in oncology to a greater number of patients compared to normal tissues.
Custom SurePrint lncRNA microarrays contain probes for >21,000 human lncRNA transcripts resulting in sensitive, efficient, and rapid interrogation of LNCipedia lncRNAs express
Agilent SurePrint G3 Gene Expression Microarrays for Human (v3), Mouse (v2) and